M28 Capital Management LP
CIK: 0001807489Latest portfolio: $137.6M · Q4 2025
Holdings
9
Total Value
$137.6M
New Positions
0
Closed Positions
0
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 5,664,548 | $96.3M | 70.00% | — | |
| 2 | IVVDINVIVYD INC | 9,248,250 | $22.8M | 16.60% | — | |
| 3 | TGTXTG THERAPEUTICS INC | 161,600 | $4.8M | 3.50% | — | |
| 4 | ARWRARROWHEAD PHARMACEUTICALS IN | 67,400 | $4.5M | 3.25% | — | |
| 5 | GUTSFRACTYL HEALTH INC | 1,856,117 | $4.1M | 2.97% | — | |
| 6 | PRQRPROQR THRAPEUTICS N V | 1,019,498 | $2.1M | 1.50% | — | |
| 7 | RCKTROCKET PHARMACEUTICALS INC | 385,680 | $1.4M | 0.98% | — | |
| 8 | SLNSILENCE THERAPEUTICS PLC | 185,100 | $1.1M | 0.82% | — | |
| 9 | CRISCURIS INC | 521,059 | $514K | 0.37% | — |
Sector Breakdown
Healthcare100.0% ($9.629722843481745e+27T)
Filing History
Fund Information
M28 Capital Management LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $137.6M across 9 holdings. The largest position is WAVE LIFE SCIENCES LTD (WVE), representing 70.0% of the portfolio. Compared to the previous quarter, the fund opened 0 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.